Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 350 of 3546 entries
View as:

A Study to Evaluate the Efficacy and Safety of Fondaparinux Sodium When Used With Intermittent Pneumatic Compression to Prevent Venous Thromboembolic (IPC) Versus IPC Alone for the Prevention of Venous Thromboembolic Events in Subjects at Increased Risk Undergoing Major Abdominal Surgery (APOLLO).

Phase: N/A Priority: Normal
NCT ID: NCT00038961 Org: User:
Start: 11/30/01 End: 10/31/04 Due: 10/31/05

Study to Asses DTPw-HBV/Hib at 15-18 Months (m) and Mencevax™ ACW at 24 to 30 m in Primed Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00317109 Org: User:
Start: 04/19/06 End: 05/17/07 Due: 05/17/08

Study to Test GSK256073 in Patients With Dyslipidemia

Phase: N/A Priority: Normal
NCT ID: NCT00903617 Org: User:
Start: 06/15/09 End: 02/16/10 Due: 02/16/11

Immune Profile in Subjects With New Onset Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT02801942 Org: User:
Start: 07/25/16 End: 12/21/17 Due: 12/21/18

A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Repeat Doses of GSK2586184 and the Effect of Food and Gender

Phase: N/A Priority: Normal
NCT ID: NCT01687309 Org: User:
Start: 04/30/12 End: 07/31/12 Due: 07/31/13

Bupropion and Specific Cardiovascular Malformations

Phase: N/A Priority: Normal
NCT ID: NCT01165255 Org: User:
Start: 06/30/10 End: 12/31/10 Due: 12/31/11

Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of GSK2831781 After an Intravenous (IV) Dose in Healthy Japanese and Caucasian Subjects, and a Subcutaneous (SC) Dose in Healthy Caucasian Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03965533 Org: User:
Start: 06/10/19 End: 12/10/19 Due: 12/10/20

A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Fluticasone Furoate Nasal Spray for 2 Weeks in Chinese Adult and Adolescent Subjects With Allergic Rhinitis

Phase: N/A Priority: Normal
NCT ID: NCT01231464 Org: User:
Start: 09/30/09 End: 07/31/10 Due: 07/31/11

Study to Assess the Safety of GSK Biologicals' Liquid Human Rotavirus Vaccine in Healthy Infants

Phase: N/A Priority: Normal
NCT ID: NCT01107587 Org: User:
Start: 04/13/10 End: 06/28/10 Due: 06/28/11

Evaluate Safety & Immunogenicity of 2 or 3 Doses of GSK HRV Vaccine in Healthy Infants in South Africa

Phase: N/A Priority: Normal
NCT ID: NCT00383903 Org: User:
Start: 09/30/03 End: 09/30/04 Due: 09/30/05

Evaluation of Immunogenicity, Safety and Reactogenicity of GSK Biologicals' Boostrix Vaccine Administered as a Booster Dose in Healthy Russian Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03311659 Org: User:
Start: 01/26/18 End: 08/31/18 Due: 08/31/19

A Study to Evaluate the Effect of Losmapimod on Cardiac Conduction as Compared to Placebo and Moxifloxacin

Phase: N/A Priority: Normal
NCT ID: NCT01756495 Org: User:
Start: 01/10/13 End: 04/23/13 Due: 04/23/14

Effect Of Carvedilol Versus Metoprolol On Glycemic Control In Patients With Type II Diabetes And Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00060931 Org: User:
Start: 06/30/01 End: 04/30/04 Due: 04/30/05

GSK2190915 Safety and Pharmacokinetic Study in Healthy Japanese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00955383 Org: User:
Start: 08/14/09 End: 10/12/09 Due: 10/12/10

A Single Dose Study to Determine the Excretion, Balance and Metabolic Disposition of Radiolabelled GW642444.

Phase: N/A Priority: Normal
NCT ID: NCT01286831 Org: User:
Start: 05/18/10 End: 07/09/10 Due: 07/09/11

24-week Trial Comparing GSK573719/GW642444 With GW642444 and With Tiotropium in Chronic Obstructive Pulmonary Disease

Phase: N/A Priority: Normal
NCT ID: NCT01316900 Org: User:
Start: 03/01/11 End: 04/24/12 Due: 04/24/13

Study to Evaluate Efficacy and Safety of Mepolizumab for Frequently Exacerbating Chronic Obstructive Pulmonary Disease (COPD) Patients

Phase: N/A Priority: Normal
NCT ID: NCT02105948 Org: User:
Start: 04/15/14 End: 01/17/17 Due: 01/17/18

A Study to Assess the Burden of Herpes Zoster and Postherpetic Neuralgia in Japanese Adults Aged Sixty Years and Above

Phase: N/A Priority: Normal
NCT ID: NCT01873365 Org: User:
Start: 06/29/13 End: 02/04/15 Due: 02/04/16

Glibenclamide (Dose to be Titrated From Starting Dose of 5mg om) Plus Rosiglitazone 4mg om (Increased to 8mg om After 6 Months) and vs Glibenclamide (Dose to be Titrated With Starting Dose of 5mg om) Plus Placebo, Administered to Patients With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT01045590 Org: User:
Start: 12/31/03 End: 02/28/06 Due: 02/28/07

Post-marketing Safety Monitoring Program of Fluticasone Propionate (FP) in Chinese Subjects With Asthma Aged 1 to <4 Years

Phase: N/A Priority: Normal
NCT ID: NCT03273946 Org: User:
Start: 01/09/18 End: 09/27/18 Due: 09/27/19

Bioavailability and Food Effect Study of Gelatin Formulation and Immediate Release Tablet Formulation of Afuresertib

Phase: N/A Priority: Normal
NCT ID: NCT02040480 Org: User:
Start: 02/05/14 End: 04/04/14 Due: 04/04/15

A Study to Characterize Event Related Potential Markers of Attentional Bias Towards Words and Images of Food

Phase: N/A Priority: Normal
NCT ID: NCT01366508 Org: User:
Start: 10/31/09 End: 10/31/10 Due: 10/31/11

A Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Seasonal Influenza Vaccine in Adults

Phase: N/A Priority: Normal
NCT ID: NCT01196975 Org: User:
Start: 10/01/10 End: 06/24/11 Due: 06/24/12

A Study to Investigate the Safety of GSK4024484 in Healthy Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT06171113 Org: User:
Start: 12/12/23 End: 08/14/25 Due: 08/14/26

Mepolizumab Steroid-Sparing Study in Subjects With Severe Refractory Asthma

Phase: N/A Priority: Normal
NCT ID: NCT01691508 Org: User:
Start: 10/31/12 End: 12/31/13 Due: 12/31/14